MedinCell S.A. provided earnings guidance for the year ending March 31, 2025. For the year, the company expects to reach revenue of EUR 100 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
15.92 EUR | -2.81% |
|
+1.14% | -4.21% |
09:28am | Medincell: two financial clauses lifted by the EIB | CF |
09:28am | Medincell: two financial clauses lifted by the EIB | CF |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- MedinCell S.A. Provides Earning Guidance for the Year Ending March 31, 2025